Product Information

PRAVASTATIN SODIUM 40 MG TAB is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0848 per EA under NDC 82009000710. Its NADAC has been published 231 times since Mar 23, 2022.

FDA first approved this application on Oct 23, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the PRAVASTATIN SODIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for PRAVASTATIN SODIUM 40 MG TAB has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 5.4%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.